Pekin Hardy Strauss’s Novo Nordisk NVO Stock Holding History

Pekin Hardy Strauss’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.36M	Buy	+70,160	New	+$3.01M	0.3%	84
2024 Q4	–	Sell	-4,165	Closed	-$496K	–	380
2024 Q3	$496K	Sell	4,165 -3,000	-42%	-$400K	0.06%	238
2024 Q2	$1.02M	Buy	7,165 +1,200	+20%	+$159K	0.14%	144
2024 Q1	$766K	Buy	5,965 +3,405	+133%	+$405K	0.1%	168
2023 Q4	$265K	Buy	+2,560	New	+$253K	0.04%	256

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Pekin Hardy Strauss's NVO Position: Q2 2026 in Review

Pekin Hardy Strauss opened a new position in Novo Nordisk (NVO) in Q2 2026: 70,160 shares worth $3.36M. The stake represents 0.3% of the portfolio and ranks #84 among its holdings. This is a return to the name: Pekin Hardy Strauss previously reported a position in NVO as recently as Q3 2024.

Pekin Hardy Strauss first reported a position in NVO in Q4 2023 and has held it in 5 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Pekin Hardy Strauss held 70,160 shares of Novo Nordisk worth $3.36M as of Q2 2026.
Novo Nordisk was a new Pekin Hardy Strauss position in Q2 2026.
Novo Nordisk made up 0.3% of Pekin Hardy Strauss's portfolio in Q2 2026, its #84 holding.
Pekin Hardy Strauss first reported a position in Novo Nordisk in Q4 2023 and has held it in 5 quarters since.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.